HOME >> BIOLOGY >> NEWS
New results validating Pall prion reduction filter disclosed at ISBT Congress

Athens, Greece (July 4, 2005) -- Safety in transfusion medicine is an ongoing challenge to blood services worldwide as new threats, such as variant Creutzfeldt-Jakob Disease (vCJD), emerge. An update on the latest measures to protect the public from the human form of Bovine Spongiform Encephalopathy (BSE), commonly called Mad Cow Disease, and minimize risk of transmission through blood transfusion was presented here at the International Society of Blood Transfusion Congress. At the "Safety in Transfusion Medicine" symposium, Pall Corporation (NYSE: PLL) released new research results further validating the performance of its Leukotrap Affinity Prion Reduction Filter System, which was CE marked with a 99.9 percent prion removal efficiency in May 2005. It is the first technology that reduces infectious prions from red cells, the most widely transfused blood component. Abnormal prions are believed to be the causative agent of vCJD.

The status of evaluations of the new filter system by blood authorities in Europe were also reported. Both the Irish Blood Transfusion Service (IBTS) and the English National Blood Service (NBS) are currently evaluating the filter system for integration into their respective practices to safeguard the blood supply from vCJD. Final results of these evaluations are expected by end 2005 or early 2006.

According to Dr. William Murphy, Medical Director of the IBTS, which just completed the first phase of its evaluation, "IBTS has completed laboratory evaluation of the filter; handling of the system is very straight forward and we are planning clinical studies in the coming months."

Dr. Roger Eglin, Head of the National Transfusion Microbiology Laboratory of the NBS, discussed the incidence and risk of vCJD transmission by blood transfusion. He reviewed the role of new technologies to reduce the risk of transfusion transmission of prions, noting that a potential impending approach is filtration.

He also discuss
'"/>

Contact: Marcia Katz
marcia_katz@pall.com
516-801-9128
Pall Corporation
4-Jul-2005


Page: 1 2 3

Related biology news :

1. Cooperative science program yields results
2. Delayed treatment of childhood-onset bipolar disorder results in negative outcome in adults
3. Smelling for first time results from knowing abnormalities in congenital loss of smell
4. BDSI announces positive phase III clinical trial results
5. Scientists meet to review Envisat results after 5 years of operations
6. Environment and exercise may affect research results, UA study shows
7. Preliminary results of largest scan of autism DNA information
8. Human trial results show excellent safety data, from Geovaxs DNA/MVA AIDS vaccines
9. Rodent sperm work together for better results
10. Dramatic results from combo therapy surprises Krabb-disease researchers
11. TIGER workshop highlights project results

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/13/2020)... LOS ANGELES (PRWEB) , ... February 13, 2020 ... ... pleased to announce an exclusive interview with Nobio CEO Yoram Ashery ... , Nobio is a company that combats bacteria to keep people healthy ...
(Date:2/11/2020)... ... February 11, 2020 , ... ... complex problems for life sciences companies and government agencies, announced the recent ... management consulting expertise to Tunnell, with significant experience assessing, designing, and managing ...
(Date:2/10/2020)... ... 10, 2020 , ... A Worcester Polytechnic Institute (WPI) bioinformatics ... (2019-nCoV), a major development that potentially holds the key to understanding the spread ... of the Wuhan coronavirus made available on the National Center for Biotechnology ...
Breaking Biology News(10 mins):
(Date:2/11/2020)... ... February 11, 2020 , ... Synagro ... North America, today announced that the City of Fort Worth has partnered with ... needs. Commencing in April of 2020, Synagro will assume operation of the city’s ...
(Date:2/5/2020)... Fla. (PRWEB) , ... February 05, 2020 , ... ... annual observance, sponsored by The National Organization for Rare Disorders (NORD), to raise awareness ... lives ( rarediseaseday.org ). The Balancing Act’s “Behind The Mystery” rare disease ...
(Date:1/28/2020)... (PRWEB) , ... January 28, 2020 , ... ... to be the exclusive distributor to food and beverage manufactures within North America. ... considered critical suppliers. This agreement will allow each company to pool their collective ...
(Date:1/27/2020)... ... January 27, 2020 , ... Cerebyte, ... cloud and mobile computing, today announced the availability of neuroscience of transformational leadership ... use the latest neuroscience of leadership and change research to become great transformational ...
Breaking Biology Technology:
Cached News: